Hiroko Hosoda

735 total citations
11 papers, 612 citations indexed

About

Hiroko Hosoda is a scholar working on Surgery, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hiroko Hosoda has authored 11 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Nephrology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hiroko Hosoda's work include Bone health and osteoporosis research (3 papers), Hormonal and reproductive studies (2 papers) and Bone health and treatments (2 papers). Hiroko Hosoda is often cited by papers focused on Bone health and osteoporosis research (3 papers), Hormonal and reproductive studies (2 papers) and Bone health and treatments (2 papers). Hiroko Hosoda collaborates with scholars based in Japan. Hiroko Hosoda's co-authors include Mai Asano, Michiaki Fukui, Goji Hasegawa, Naoto Nakamura, Toshikazu Yoshikawa, Mitsuhiro Ohta, Hiroshi Obayashi, Jo Kitawaki, Koji Nakano and Tetsuo Adachi and has published in prestigious journals such as Diabetes Care, Kidney International and European Journal of Pharmacology.

In The Last Decade

Hiroko Hosoda

10 papers receiving 599 citations

Peers

Hiroko Hosoda

SURGE

PHYSI

MB

NEPHR

DN

Ryoichi Nakazawa Japan

Petra J. Ottens Netherlands

Stefan‐Mario Kasper Germany

Harshini Mudaliar Australia

Christian Negut Italy

Derya Aldemir Türkiye

Youling Fan China

Hung Cao-Danh United States

Yuxia Gao China

Ryoichi Nakazawa Japan

Hiroko Hosoda

227 ×0.7

SURGE

145 ×0.7

PHYSI

94 ×0.6

MB

131 ×1.4

NEPHR

54 ×0.6

DN

Citations per year, relative to Hiroko Hosoda Hiroko Hosoda (= 1×) peers Ryoichi Nakazawa

Countries citing papers authored by Hiroko Hosoda

Since Specialization

Citations

This map shows the geographic impact of Hiroko Hosoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Hosoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Hosoda more than expected).

Fields of papers citing papers by Hiroko Hosoda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Hosoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Hosoda. The network helps show where Hiroko Hosoda may publish in the future.

Co-authorship network of co-authors of Hiroko Hosoda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Hosoda. A scholar is included among the top collaborators of Hiroko Hosoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Hosoda. Hiroko Hosoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Hasegawa, Goji, Michiaki Fukui, Hiroko Hosoda, et al.. (2009). Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats. European Journal of Pharmacology. 605(1-3). 164–169. 29 indexed citations

2.

Asano, Mai, Michiaki Fukui, Hiroko Hosoda, et al.. (2008). Bone stiffness in men with type 2 diabetes mellitus. Metabolism. 57(12). 1691–1695. 6 indexed citations

3.

Fukui, Michiaki, Muhei Tanaka, Hiroko Hosoda, et al.. (2008). Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism. 57(5). 625–629. 102 indexed citations

4.

Fukui, Michiaki, Muhei Tanaka, Hiroko Hosoda, et al.. (2008). Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney International. 74(9). 1197–1201. 97 indexed citations

5.

Hasegawa, Goji, Mai Asano, Hiroko Hosoda, et al.. (2008). Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutrition Research. 28(3). 137–143. 322 indexed citations

6.

Hosoda, Hiroko, Michiaki Fukui, Mai Asano, et al.. (2008). Bone mass and bone resorption in postmenopausal women with type 2 diabetes mellitus. Metabolism. 57(7). 940–945. 9 indexed citations

7.

Fukui, Michiaki, Hiroko Hosoda, Mai Asano, et al.. (2007). Association between serum testosterone concentration and collagen degradation fragments in men with type 2 diabetes mellitus. Metabolism. 56(9). 1228–1232. 4 indexed citations

8.

Hasegawa, Goji, Mai Asano, Hiroko Hosoda, et al.. (2007). Killer cell immunoglobulin‐like receptor genotypes in Japanese patients with type 1 diabetes. Tissue Antigens. 70(6). 506–510. 22 indexed citations

9.

Fukui, Michiaki, Hiroko Hosoda, Mai Asano, et al.. (2007). Association Between Urinary Albumin Excretion and Serum Dehydroepiandrosterone Sulfate Concentrations in Women With Type 2 Diabetes. Diabetes Care. 30(7). 1886–1888. 8 indexed citations

10.

Nakajima, Toshiki, Goji Hasegawa, Michiaki Fukui, et al.. (2006). Differential regulation of intracellular redox state by extracellular matrix proteins in glomerular mesangial cells: potential role in diabetic nephropathy. Redox Report. 11(5). 223–230. 13 indexed citations

11.

Hosoda, Hiroko, et al.. (1974). The Quantitative Changes in the Chemical Components of Fruits Juices during Storage. Eiyo to shokuryo. 27(3). 139–141.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact